Impact of a Stage IV NSCLC Care Pathway on Frontline and Maintenance Chemotherapy Use

July 7, 2015
James Stevenson, MD

James Stevenson, MD, Department of Hematology and Oncology, Cleveland Clinic, discusses the impact of a stage IV non-small cell lung cancer (NSCLC) care pathway on frontline and maintenance chemotherapy use.